Table 1.
Gene | Reference | Polymorphism | Cases, n; controls, n | Results |
Factor V | Catto et al., 1995 [56]; Catto et al., 1996 [57] | G1691A | 348; 247 | Negative |
Kontula et al., 1995 [58] | G1691A | 236; 137 | Negative | |
Ridker et al., 1995 [15] | G1691A | 209; 209 | Negative | |
Martinelli et al., 1997 [59] | G1691A | 155; 155 | Negative | |
Press et al., 1996 [60] | G1691A | 116; 54/161/287 | Negative | |
van der Bom et al., 1996 [61] | G1691A | 112; 222 | Negative | |
Longstreth et al., 1998 [62] | G1691A | 106; 391 | Negative | |
Halbmayer et al., 1997 [63] | G1691A | 229; 71 | Negative | |
Markus et al., 1996 [64] | G1691A | 180; 80 | Negative | |
Factor VII | Nishiuma et al., 1997 [65] | R353Q | 137; 83/87 | Negative |
Heywood et al., 1997 [66] | R353Q | 286; 198 | Negative | |
Corral et al., 1998 [67] | R353Q/323A2 | 104; 104 | Negative | |
Factor XIII | Catto et al., 1998 [68] | Val34Leu | 529; 437 | Negative |
β-Fibrinogen | Schmidt et al., 1998 [11] | C148T | 399 | Positive |
Carter et al., 1997 [12] | G448A | 305; 197 | Positive | |
Kessler et al., 1997 [10] | G455A | 227; 225 | Positive | |
GPIa/IIa | Carlsson et al., 1999 [13] | C807T | 227; 170 | Positive |
Carlsson et al., 1997 [69] | HPA-5 | 218; 165/321 | Negative | |
GPIbα | Gonzalez-Conejero et al., 1998 [14] | VNTR | 104; 104 | Positive |
HPA-2 | 104; 104 | Positive | ||
GPIIb/IIIa | Carter et al., 1998 [16] | P1A2 | 505; 402 | Positive |
Ridker et al., 1997 [70] | P1A2 | 209; 209 | Negative | |
Carlsson et al., 1997 [69] | HPA-1 | 218; 165/321 | Negative | |
HPA-3 | 218; 165/321 | Negative | ||
PAI 1 | Catto et al., 1997 [71] | 4G/5G | 421; 172 | Negative |
Prothrombin | Longstreth et al., 1998 [62] | G20210A | 106; 391 | Negative |
Poort et al., 1996 [72] | G20210A | 104; 104 | Negative | |
Martinelli et al., 1997 [59] | G20210A | 155; 155 | Negative | |
Ridker et al., 1999 [73] | G20210A | 259; 1,744 | Negative |
GP, glycoprotein; PAI, plasminogen activator inhibitor.